Cross Country Healthcare (CCRN) EBIT (2010 - 2026)

Cross Country Healthcare has reported EBIT for 17 years, with the latest figure at -$4.2 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 325.28% year-over-year to -$4.2 million; the trailing twelve-month figure through Mar 2026 stood at -$87.6 million (down 321.87% YoY), and the FY2025 full-year result was -$84.4 million, down 400.53% from the prior year.
• EBIT for Q1 2026 stood at -$4.2 million, up from -$71.6 million in the prior quarter.
• The five-year high for EBIT was $90.6 million in Q1 2022, with the low at -$71.6 million in Q4 2025.
• Historically, EBIT has averaged $16.3 million across 5 years, with a median of $2.9 million in 2024.
• Annual changes were most pronounced in 2022 — EBIT surged 395.8% — and 2025, when it slumped 1985.79%.
• Cross Country Healthcare's EBIT stood at $48.2 million in 2022, then slumped by 72.17% to $13.4 million in 2023, then plunged by 125.57% to -$3.4 million in 2024, then tumbled by 1985.79% to -$71.6 million in 2025, then jumped by 94.2% to -$4.2 million in 2026.
• The last three EBIT figures came in at -$4.2 million (Q1 2026), -$71.6 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.